Active Biotech AB Stock Xetra
Equities
BTPC
SE0001137985
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- EUR | - |
Sales 2023 | - | Sales 2024 * | - | Capitalization | 193M 17.76M 16.54M |
---|---|---|---|---|---|
Net income 2023 | -45M -4.14M -3.86M | Net income 2024 * | -43M -3.96M -3.69M | EV / Sales 2023 | - |
Net cash position 2023 | 36.2M 3.33M 3.11M | Net cash position 2024 * | - 0 0 | EV / Sales 2024 * | - |
P/E ratio 2023 * |
-
| P/E ratio 2024 * |
-
| Employees | - |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 70.39% |
Managers | Title | Age | Since |
---|---|---|---|
Helén Tuvesson
CEO | Chief Executive Officer | 62 | 97-12-31 |
Hans Kolam
DFI | Director of Finance/CFO | 73 | 99-12-31 |
Erik Vahtola
CTO | Chief Tech/Sci/R&D Officer | - | 21-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Uli Alf Hacksell
BRD | Director/Board Member | 74 | 19-05-22 |
Director/Board Member | 50 | 19-12-31 | |
Michael Shalmi
CHM | Chairman | 59 | 19-05-22 |
1st Jan change | Capi. | |
---|---|---|
-2.26% | 103B | |
+1.41% | 95.71B | |
+0.70% | 22.02B | |
-17.84% | 20.9B | |
-10.14% | 17.85B | |
-42.83% | 16.21B | |
-17.63% | 15.52B | |
+4.55% | 13.86B | |
+32.11% | 12.04B |
- Stock Market
- Equities
- ACTI Stock
- BTPC Stock